Fresenius (company)
 | |
| Company type | Public |
|---|---|
| ISIN | DE0005785604  |
| Industry | Health care |
| Founded | 1912 |
| Headquarters |  Bad Homburg, Germany |
Key people | Ulf M. Schneider (Chairman of the management board), Gerd Krick (Chairman of the supervisory board) |
| Products | Kidney dialysis Infusion pumps and drugs hospitals medical care of patients at home |
| Revenue | €10.777 billion (2006)[1] |
Number of employees | 104,800 (2006)[1] |
| Website | www.fresenius.se |
Fresenius SE (FWB: FREG) is a health care company with approximately 100,000 employees, based in Bad Homburg, Germany.
Fresenius consists of three wholly-owned business units, Fresenius Biotech, Fresenius Kabi and Fresenius ProServe, and holds approximately 37% of Fresenius Medical Care.[2]
Fresenius owned the Helios Kliniken with over 60 hospitals with over 17.500 beds and over 500.000 patients. It's the biggest hospital company in germany.
The American branch is headquartered in Waltham, Massachusetts.
On 2007-07-16, the company completed its conversion from an Aktiengesellschaft (AG -- German public limited company) to a Societas Europaea, a European Union-wide equivalent.[3]
References
- ^ a b Fresenius SE. "Fresenius Annual Report 2006" (PDF). Retrieved 2007-08-12.
- ^ Fresenius Medical Care. "Capital structure". Retrieved 2007-08-12.
- ^ Fresenius SE (2007-07-16). "Fresenius completes conversion into a European Company (SE)". Retrieved 2007-08-12.
{{cite web}}: Check date values in:|date=(help)
External links
 | This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it. |
 | This German corporation or company article is a stub. You can help Wikipedia by expanding it. |